BIO-TECHNE Corp Quarterly Amortization of Intangible Assets in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
BIO-TECHNE Corp quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2010 to Q3 2024.
  • BIO-TECHNE Corp Amortization of Intangible Assets for the quarter ending September 30, 2024 was $20M, a 0.94% decline year-over-year.
  • BIO-TECHNE Corp annual Amortization of Intangible Assets for 2024 was $79.9M, a 3.05% increase from 2023.
  • BIO-TECHNE Corp annual Amortization of Intangible Assets for 2023 was $77.5M, a 4.51% increase from 2022.
  • BIO-TECHNE Corp annual Amortization of Intangible Assets for 2022 was $74.1M, a 14.2% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $20M -$191K -0.94% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q3 2023 $20.2M +$727K +3.73% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q3 2022 $75M $19.5M +$898K +4.83% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $74.1M -$37.4M Apr 1, 2022 Jun 30, 2022 10-K 2023-08-23
Q1 2022 $55.7M Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $37.3M Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $18.6M +$3.03M +19.5% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-08
Q3 2020 $15.6M +$626K +4.19% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q3 2019 $14.9M +$636K +4.44% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-06
Q3 2018 $14.3M +$2.93M +25.8% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-07
Q3 2017 $11.4M +$1.19M +11.7% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q3 2016 $10.2M +$2.78M +37.5% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-09
Q4 2015 $7.36M +$503K +7.33% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $7.41M +$1.68M +29.4% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q1 2015 $6.75M +$4.15M +159% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $6.86M +$4.27M +165% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $5.73M +$3.54M +162% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q1 2014 $2.61M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.59M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $2.19M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q1 2011 $170K -$70K -29.2% Jan 1, 2011 Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $171K Oct 1, 2010 Dec 31, 2010 10-Q 2011-02-09
Q3 2010 $170K Jul 1, 2010 Sep 30, 2010 10-Q 2010-11-09
Q1 2010 $240K Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.